PUBLIC SAFETY AND LEGAL LIABILITY ARISING FROM OVER-SCREENING OF POPULATIONS

1. INTRODUCTION

Over-screening populations refers to the excessive or unnecessary medical testing of large groups of apparently healthy individuals for detecting diseases, genetic abnormalities, infections, cancers, or other health conditions. Although population screening can support early diagnosis and disease prevention, excessive screening without sufficient scientific justification can create significant public safety risks.

Over-screening may result in false-positive findings, overdiagnosis, unnecessary medical interventions, psychological distress, exposure to radiation, financial burdens, and inappropriate allocation of healthcare resources. It can also compromise individual autonomy, privacy, and informed consent. Consequently, governments, healthcare institutions, laboratories, and medical practitioners have legal responsibilities to ensure that population-screening programmes are scientifically justified, proportionate, transparent, and ethically acceptable.

2. MAJOR PUBLIC SAFETY CONCERNS

A. FALSE-POSITIVE RESULTS

Excessive screening increases the possibility that healthy individuals will receive abnormal or misleading results. Such findings may lead to unnecessary biopsies, additional diagnostic procedures, medication, and surgical interventions. Healthcare institutions may face negligence claims where screening procedures are inadequately designed or results are improperly communicated.

B. OVERDIAGNOSIS AND OVERTREATMENT

Overdiagnosis occurs when screening identifies conditions that would never have caused symptoms or serious health consequences during an individual's lifetime. Treating such conditions unnecessarily can expose individuals to surgical complications, medication-related injuries, and permanent physical consequences.

C. PSYCHOLOGICAL AND SOCIAL HARM

Individuals receiving uncertain or abnormal screening results may experience anxiety, depression, fear, and social stigma. Screening programmes involving genetic or infectious disease information may additionally expose individuals to discrimination in employment, insurance, or social relationships.

D. UNNECESSARY EXPOSURE TO MEDICAL PROCEDURES

Repeated imaging, invasive diagnostic procedures, biopsies, and radiation-based investigations may expose otherwise healthy individuals to avoidable medical risks. Screening providers must assess whether the expected benefits justify these risks.

E. MISALLOCATION OF PUBLIC HEALTH RESOURCES

Excessive screening can consume financial resources, laboratory capacity, medical personnel, and diagnostic facilities. Consequently, individuals with actual symptoms or serious medical conditions may experience delays in receiving necessary healthcare.

F. PRIVACY AND CONFIDENTIALITY VIOLATIONS

Large-scale screening frequently involves collecting sensitive medical, genetic, and personal information. Unauthorized disclosure, inadequate data protection, or inappropriate secondary use of screening records can violate individual privacy and constitutional protections.

3. LEGAL AND REGULATORY FRAMEWORK IN INDIA

Several legal principles govern the safety and administration of population-screening activities.

Constitution of India, Article 21: Protects life, personal liberty, dignity, and privacy. Public health interventions must respect individual rights and satisfy applicable constitutional requirements.

Consumer Protection Act, 2019: Healthcare providers may face liability for deficient medical services, misleading representations, and negligence falling within the applicable consumer-law framework.

Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002: The professional duties reflected in these regulations require appropriate medical conduct, confidentiality, and responsible patient care, subject to the applicable regulatory framework.

Digital Personal Data Protection Act, 2023: Provides a statutory framework for processing digital personal data, subject to its applicability, commencement provisions, and applicable exemptions.

Biomedical and Health Research Ethics: ICMR's National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, provide important standards concerning informed consent, participant welfare, confidentiality, and ethical review.

4. IMPORTANT CASE LAWS

1. Samira Kohli v. Dr. Prabha Manchanda (2008) — DIRECT AUTHORITY ON INFORMED CONSENT

The Supreme Court of India emphasized that valid medical consent must be voluntary and based on adequate information. Consent for one procedure cannot automatically authorize additional or substantially different procedures.

Relevance: Screening programmes should communicate the nature, purpose, limitations, and potential consequences of testing before obtaining consent.

2. Indian Medical Association v. V.P. Shantha (1995) — DIRECT AUTHORITY ON MEDICAL SERVICE LIABILITY

The Supreme Court examined the applicability of consumer-protection law to medical services.

Relevance: Deficiencies in screening-related medical services may attract consumer-law liability where the statutory requirements are satisfied.

3. Jacob Mathew v. State of Punjab (2005) — DIRECT AUTHORITY ON MEDICAL NEGLIGENCE

The Supreme Court explained the standards governing medical negligence and distinguished civil negligence from the higher threshold applicable to criminal medical negligence.

Relevance: Screening professionals must exercise reasonable competence and professional care when recommending, conducting, and interpreting medical investigations.

4. Kusum Sharma v. Batra Hospital and Medical Research Centre (2010) — ANALOGOUS AUTHORITY

The Supreme Court explained that medical professionals must exercise reasonable skill and care according to accepted professional standards.

Relevance: Unjustified screening recommendations, careless interpretation, and failure to follow appropriate medical standards may support negligence claims.

5. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) — DIRECT CONSTITUTIONAL AUTHORITY

The Supreme Court recognized privacy as a fundamental right under Article 21 and established legality, legitimate state purpose, and proportionality as important requirements for restricting privacy.

Relevance: Population-screening programmes involving personal and genetic information must respect privacy, confidentiality, and proportionality.

6. Spring Meadows Hospital v. Harjol Ahluwalia (1998) — ANALOGOUS AUTHORITY

The Supreme Court considered medical negligence and the responsibilities arising from healthcare services.

Relevance: Healthcare institutions may be accountable for failures in professional supervision and the delivery of appropriate medical services.

7. Helling v. Carey (1974) — ANALOGOUS FOREIGN AUTHORITY

The Washington Supreme Court considered a physician's failure to conduct a relatively simple glaucoma test despite the patient's age-related risk.

Relevance: The decision illustrates that reasonable screening precautions may sometimes be necessary even where established professional practices do not adequately address foreseeable risks. It does not establish that indiscriminate screening is legally required.

5. LEGAL RESPONSIBILITIES AND COMPLIANCE REQUIREMENTS

Healthcare institutions and screening authorities should:

Establish scientifically validated eligibility criteria for screening.

Demonstrate that expected health benefits outweigh potential harms.

Obtain appropriate informed consent before testing.

Explain false-positive results, false negatives, and overdiagnosis.

Provide confirmatory diagnostic procedures and appropriate follow-up.

Maintain confidentiality and secure personal health information.

Avoid discriminatory screening practices.

Conduct independent ethical and scientific assessments where required.

Monitor adverse outcomes and periodically reassess programme effectiveness.

Ensure that individuals are not subjected to unnecessary treatment solely because of preliminary screening findings.

6. CONCLUSION

Over-screening populations presents important public safety, constitutional, ethical, and medical negligence concerns. Although early detection can improve public health outcomes, excessive screening without reliable scientific evidence can expose healthy individuals to unnecessary investigations, psychological harm, overdiagnosis, and overtreatment.

Indian constitutional principles, medical negligence jurisprudence, consumer-protection legislation, and privacy requirements collectively provide safeguards against irresponsible screening practices. The decisions in Samira Kohli, Jacob Mathew, Kusum Sharma, and Puttaswamy establish particularly important principles concerning consent, professional responsibility, and individual rights.

Ultimately, population-screening programmes must follow evidence-based selection criteria, proportionality, informed consent, confidentiality, and continuous safety monitoring. Public health protection should prioritize genuine medical benefits rather than the unnecessary expansion of screening activities.